HomeFileStructural heart disease

Structural heart disease

TriClip: Good Outcomes After a 2-Year Follow-up

Severe tricuspid regurgitation (TR) is an underestimated condition in healthcare systems. However, it is more common than...

TRILUMINATE Two Years In: Encouraging Results

Tricuspid valve regurgitation is more common than one might think. It often stems from left valve disease...

Hypertrophic Cardiomyopathy: Long Term Survival with Alcohol Septal Ablation according to Hemodynamic Variables

Left ventricular outflow tract (LVOT) obstruction is an integral component of hypertrophic cardiomyopathy (HCM). Both chemical myomectomy...

TAVI-in-TAVI with Balloon-Expandable Valves

TAVI (Transcatheter Aortic Valve Implantation) has proven to be beneficial and is currently performed in increasingly younger...

Post-TAVI Prosthesis-Patient Mismatch

Prosthesis-patient mismatch (PPM) occurs when the effective orifice area (EOA) after valve placement is significantly smaller compared...

Predictors and Evolution of Need for PPM after TAVR with Self-Expanding Valves

In the context of TAVR, one of the current challenges is the need for permanent pacemaker implantation...

ESC 2023 | BUDAPEST CRT Upgrade trial

Approximately 1 million pacemakers (PM) or Implantable cardioverter-defibrillators (ICDs) are placed every year around the world, and...

Left Atrial Appendage Occlusion: Clinical Outcomes according to Device Implantation Depth

Continuous improvement of left atrial appendage occlusion (LAAO) devices has had a positive impact on the safety...